Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer
Clinical trial NCT02002312 · COMPLETED
Trial details
- NCT number
- NCT02002312
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2015-06-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.